1. Home
  2. SGRP vs NNVC Comparison

SGRP vs NNVC Comparison

Compare SGRP & NNVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SPAR Group Inc.

SGRP

SPAR Group Inc.

HOLD

Current Price

$0.75

Market Cap

18.2M

ML Signal

HOLD

NNVC

NanoViricides Inc.

HOLD

Current Price

$1.38

Market Cap

21.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SGRP
NNVC
Founded
1967
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.2M
21.2M
IPO Year
1996
2008

Fundamental Metrics

Financial Performance
Metric
SGRP
NNVC
Price
$0.75
$1.38
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
50.8K
1.0M
Earning Date
03-31-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
10.00
EPS
N/A
N/A
Revenue
$136,104,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.50
$0.85
52 Week High
$1.41
$2.23

Technical Indicators

Market Signals
Indicator
SGRP
NNVC
Relative Strength Index (RSI) 61.64 43.38
Support Level $0.74 $1.35
Resistance Level $0.80 $1.52
Average True Range (ATR) 0.04 0.16
MACD 0.00 -0.04
Stochastic Oscillator 70.56 0.88

Price Performance

Historical Comparison
SGRP
NNVC

About SGRP SPAR Group Inc.

SPAR Group Inc is a merchandising and brand marketing services company, providing a broad range of sales-enhancing services to retailers across classes of trade and consumer goods manufacturers and distributors. The company provides five principal types of services: Merchandising, Marketing and Category Management, Remodel and Retail Transformation, Assembly and Installation, Fulfilment and Distribution, and Business Analytics and Insights. It operates in two segments, namely the U.S. and Canada, with the majority of the revenues deriving from the U.S. segment.

About NNVC NanoViricides Inc.

Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.

Share on Social Networks: